Supersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stability

dc.accessRightsAnonymous*
dc.audienceScienceen_US
dc.contributor.authorIlie, Alexandra Roxana
dc.contributor.authorKuentz, Martin
dc.date.accessioned2020-03-03T08:31:59Z
dc.date.available2020-03-03T08:31:59Z
dc.date.issued2020-01-24
dc.description.abstractObjective: The objective of this study was to systematically investigate the impact of lipid composition on the ability to design supersaturated lipid-based drug delivery systems (sLBDDS) using three model drugs with different physico-chemical properties.Significance: This study expands the list of investigated sLBDDS by using alternative vehicle compositions relative to current literature.Methods and results: Drug supersaturation was thermally-induced based on previously reported methods and was successfully achieved for celecoxib and cinnarizine. For the novel drug, JNJ-2A, a lower supersaturation potential was observed for the tested LBDDS. For celecoxib and cinnarizine, crystalline precipitate was observed for some sLBDDS upon storage at 25 °C/65%RH, particularly for medium chain sLBDDS (celecoxib) and long chain sLBDDS (cinnarizine). The greater risk of precipitation observed for celecoxib and cinnarizine, particularly at higher apparent degree of supersaturation (aDS) may be related to their higher crystallization tendency as determined by differential scanning calorimetry.Conclusions: The potential for supersaturation in LBDDS, and the risk of precipitation, was found to be highly drug dependent. The apparent degree of supersaturation was considered a major factor impacting the ability to maintain drug supersaturation upon storage.en_US
dc.description.urihttps://www.ncbi.nlm.nih.gov/pubmed/31975613en_US
dc.identifier.doi10.1080/03639045.2020.1721526
dc.identifier.issn0363-9045
dc.identifier.issn1520-5762
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/30642
dc.language.isoenen_US
dc.publisherMarcel Dekkeren_US
dc.relation.ispartofDrug Development and Industrial Pharmacyen_US
dc.subjectpre-formulationen_US
dc.subjectSupersaturated lipid-based drug delivery systemsen_US
dc.subjectformulation developmenten_US
dc.subjectphysical stabilityen_US
dc.subjectsolubility screeningen_US
dc.titleSupersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stabilityen_US
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dspace.entity.typePublication
fhnw.InventedHereYesen_US
fhnw.IsStudentsWorknoen_US
fhnw.PublishedSwitzerlandYesen_US
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publicationen_US
fhnw.affiliation.hochschuleHochschule für Life Sciencesde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.pagination1-29en_US
fhnw.publicationOnlineJaen_US
fhnw.publicationStatePublisheden_US
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien